<< Back to All Newsletters Scientists are chasing the perfect high
NewYorkTimes.com
OUR TAKEAWAY
"The cannabis business has arrived at a critical moment. Customers are increasingly seeking the same "proven consistency" that they expect from potato chips and soap. The financial stakes are clear: Despite lingering prohibitions in 17 states, legal cannabis is already an $8 billion industry in the United States. Domestic sales of alcohol, humankind's other favorite intoxicant, topped $200 billion last year. But to make cannabis as popular as booze requires solving that original problem: It's hard to imagine millions of people becoming new recreational users without being able to promise them that the product they're spending money on will give them the effect they want."
Cannabinoids can help with everyday ailments
SDCityBeat.com
OUR TAKEAWAY
There has been a lack of cannabinoid research due to years of prohibition. Scientists are just beginning to scratch the surface on the potential of the 100 different (possibly more) cannabinoids of the cannabis plant.
How cannabis and humans evolved together
Leafly.com
OUR TAKEAWAY
Homo sapiens have a long, beneficial, and evolutionary relationship with cannabis, according to Dr. Sunil K. Aggarwal, a physician, medical geographer, and co-founder of the Advanced Integrative Medical Science Institute in Seattle.
Cannabis 101: CBG or cannabigerol, the next CBD?
Benzinga.com
OUR TAKEAWAY
Cannabis is a chemical powerhouse, with over 500 different compounds, including 100 cannabinoids, found within one plant. While CBD and THC are the most common cannabinoids, others are starting to make a splash. CBG (cannabigerol) has been called the "mother of all cannabinoids" because it can be converted into various other cannabinoids. Potential health benefits from CBG could include the management of pain, sleep, blood pressure, inflammation, anxiety, and gut health.
OUR TAKEAWAY
The Rising Tide of Legalization: April 3, 2020
The tide of cannabis legalization across the United States continues to rise despite difficult macro market conditions, and we believe the “Rising Tide of Legalization” will provide an enormous tailwind to the cannabis industry. Support among Americans for cannabis legalization continues to rise, and many government entities count on cannabis-derived taxes as a meaningful source of revenue. Even in these difficult times of COVID-19, we see vast potential for the industry. Numerous municipalities depend on tax revenue from the industry and have declared cannabis an “essential service” during this period of uncertainty. The tide continues to shift, and we see promise ahead.
CONTINUE READING